Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of LianXiaXiaoPi Granule for functional dyspepsia
CTR20210359Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lianxia Xiaopi Granules in functional dyspepsia (FD), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started May 2021; status: completed.
02
Drugs
Lianxia Xiaopi Granules
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on CTR20210359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210359.